Humulin R
Alzheimer Disease, Early Onset
Wake Forest University Health SciencesPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
20 Active assets in the Alzheimer Disease, Early Onset cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Sra-333 Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
Gonadotropin-Releasing Hormone Nelly Pitteloud | Phase 2/3 | CCC |
Gnrh Nelly Pitteloud | Phase 2/3 | CCC |
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION Nelly Pitteloud | Phase 2/3 | CCC |
ad-35 Zhejiang Hisun Pharmaceutical Co. Ltd. | Phase 2 | CCC |
View all 25 →
Same molecule, other indications
Humulin R is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →